Liesbeth E. Jonges

Caspase-3 Activity as a Prognostic Factor in Colorectal Carcinoma

Liesbeth E. Jonges, J. Fred Nagelkerke, N. Geeske Ensink et al. · Laboratory Investigation · 2001 · 94 citations

Tumor Biology, Oncology, Caspase-3 Activity +6

The Phenotypic Heterogeneity of Human Natural Killer Cells: Presence of at least 48 Different Subsets in the Peripheral Blood

Liesbeth E. Jonges, Per Albertsson, Ronald L. P. van Vlierberghe et al. · Scandinavian Journal of Immunology · 2001 · 71 citations

Efficient direct priming of tumor-specific cytotoxic T lymphocyte in vivo by an engineered APC.

Stephen P. Schoenberger, Liesbeth E. Jonges, Rob J.D. Mooijaart et al. · PubMed · 1998 · 66 citations

High Density, Cancer Immunosurveillance, Engineered Apc +15

Tumor structure and extracellular matrix as a possible barrier for therapeutic approaches using immune cells or adenoviruses in colorectal cancer

Peter J.K. Kuppen, M.M. van der Eb, Liesbeth E. Jonges et al. · Histochemistry and Cell Biology · 2000 · 63 citations

Oncology, Medicine, Immunology +8

Recombinant adenoviral vectors have adjuvant activity and stimulate T cell responses against tumor cells

Sacha B. Geutskens, M.M. van der Eb, Arianne C. Plomp et al. · Gene Therapy · 2000 · 52 citations

Cancer Immunosurveillance, Recombinant Adenoviral Vectors, Immunology +9